Severe Sporadic Primary Hyperparathyroidism Masquerading as Hyperparathyroidism Jaw Tumor Syndrome
Clinical Case Reports · 2026-04 · 14 (4)
DOI: 10.1002/ccr3.72432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 01.04.2026. Verfasst von Brook Alemayehu Tesfaye und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Jaw lesions are rare in Primary hyperparathyroidism (PHPT) and often mimic odontogenic tumors or syndromic conditions such as hyperparathyroidism Jaw Tumor (HPT‐JT) syndrome. We describe a 29 years old Ethiopian woman who presented with an 8‐month history of progressive left maxillary swelling and a 3‐year history of lower leg pain. Imaging revealed an expansile lesion in the left maxilla and multiple cortical lesions in the tibia and fibula. She later developed symptomatic hypercalcemia; primary hyperparathyroidism was diagnosed. She developed hungry bone syndrome after undergoing parathyroidectomy, which required aggressive calcium and vitamin D supplementation. She was discharged with improvement of clinical and lab parameters.
Zitieren
APA
Tesfaye, B. A., Museyd, H., Alemayehu, D., Aberra, T., & Amogne, M. T. (2026). Severe Sporadic Primary Hyperparathyroidism Masquerading as Hyperparathyroidism Jaw Tumor Syndrome. Clinical Case Reports, 14(4). https://doi.org/10.1002/ccr3.72432
Vancouver
Tesfaye BA, Museyd H, Alemayehu D, Aberra T, Amogne MT. Severe Sporadic Primary Hyperparathyroidism Masquerading as Hyperparathyroidism Jaw Tumor Syndrome. Clinical Case Reports. 2026;14(4). doi:10.1002/ccr3.72432
BibTeX
@article{Tesfaye2026,
author = {Tesfaye, Brook Alemayehu and Museyd, Heykel and Alemayehu, Dawit and Aberra, Theodros and Amogne, Melaku Taye},
title = {Severe Sporadic Primary Hyperparathyroidism Masquerading as Hyperparathyroidism Jaw Tumor Syndrome},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/ccr3.72432}
}
EUVIMED